AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...

After the airing of his special report on living with Parkinson's disease, CBS News Miami's Ted Scouten shares a story about ...

Some people with Parkinson’s Disease are turning to improv to boost their cognitive skills and spend more time with others.

Over 9 million individuals globally struggle with Parkinson's disease, facing symptoms like tremors and mobility freezes that ...

An elderly Oklahoma woman stricken with Parkinson’s Disease lost $20,000 in a cryptocurrency ploy that was crafted as a scam ...

You’re never too young to make a difference. Zachery Hunter has been working with Parkinson’s In Motion, a local 501©(3) ...

The Lafayette Area Parkinson's Support, known as LeAPS, is a new nonprofit that will be offered to those impacted by ...

A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...

A team of Tel Aviv University researchers claims to have made progress in the path to treating Parkinson’s disease. The team found that a variant of a protein, caused by a genetic mutation, enhances ...